Senior insider sale
Chief Financial Officer at XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$378.9K
45K shares
What this filing means
PIEPER STEVEN plans to sell 45K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $378.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/7/2026ACC: 0001950047-26-006941
Officer· Chief Financial Officer
Since Oct 2021
45K
Shares to sell
$378.9K
Approx. market value
27.60K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Restricted Stock Units
N/A
12/28/2017
23KOpen Market Purchase
Cash
5/17/2017
4.60KTotal acquired27.60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/28/2017 | Restricted Stock Units N/A | 23K | — |
5/17/2017 | Open Market Purchase Cash | 4.60K | — |
| Total | 27.60K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
17.40K
Market value
$147.9K
7/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
27.60K
Market value
$231.0K
7/7/2026
Total
Units
45K
Value
$378.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/6/2026 | 17.40K | $147.9K | — | Completed |
| Planned — Approximate Date | ||||
7/7/2026 | 27.60K | $231.0K | NASDAQ | Planned |
| Total | 45K | $378.9K | ||